Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-031-5 | CAS number: 10024-93-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity on test material
Under the conditions of this study, the oral LD50 value of the test material in Sprague-Dawley rats was estimated to be 5068 mg/kg.
Acute dermal toxicity
Under the conditions of this study no mortality was observed at 2000 mg/kg.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: Directive 79/831 de la C.E.E –annexe V partie B
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 6 to 7 weeks
- Weight at study initiation: 160 to 200 g (males), 140 to 180 g (females)
- Fasting period before study: Animals were subjected to a water diet from 17 to 19 hours before the treatment until three hours after treatment.
- Housing: plastic cages (36.5 x 22.5 x 18.0 cm) containing sterilised sawdust
- Diet: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 1.5 °C
- Humidity: 55 ± 15 %
- Air changes: 10 per hour - Route of administration:
- oral: unspecified
- Vehicle:
- water
- Details on oral exposure:
- Administration
- Doses: 3980, 5000, 5620 and 6300 mg/kg (Main test)
- Administrtaion volume: 10 mL/kg
- Rationale for the selection of the starting dose: Results of the preliminary study - Doses:
- Preliminary study: 1000, 2500 and 5000 mg/kg
Main study: 3980, 5000, 5620 and 6300 mg/kg - No. of animals per sex per dose:
- 5 animals per sex per dose (Main study)
2 animals per sed per dose (Preliminary study) - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Behavior and mortality were observed after the administration of the test material then 1 hour, 2 hours, 4 hours after and every day for 14 days. Body weighing was performed at -1, 0, 7 and 14 days and at the death of the animal if it has survived more than 24 hours.
- Necropsy of survivors performed: yes autopsy was performed on animals found dead or sacrificed at the end of the observation period. - Statistics:
- No statistical analysis was performed (the method used is not intended to allow the calculation of a precise LD50 value).
- Preliminary study:
- A preliminary study was performed on 2 males and 2 females at 1000, 2500 and 5000 mg/kg bw. During the preliminary study no mortality was observed at 1000 and 2500 mg/kg but 50 % mortality was seen at 5000 mg/kg.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 5 068 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: estimated value
- Mortality:
- 1 female dosed at 3980 mg/kg died on day 1, 2 males at the same dose level died on day 2.
All of the males dosed at 5000 mg/kg survived, 2 females died on day 1 and a further female died on day 4.
In the 5620 mg/kg dose group, 2 males died on day 4 with a third male dying on day 7. 2 females of the same dose group died on day 1.
In the 6300 mg/kg dose group, 1 male died on day 2, a further 2 males died on day 4 and a further male died on day 7. 3 females of the same dose group died on day 1, a further female died on day 7. - Clinical signs:
- other: Clinical signs recorded during the study period included ataxia, piloerection, and ptosis with abdominal distension occurring at the higher doses. At the end of the 14-day observation period, the surviving animals treated at 5620 mg/kg had not all recover
- Gross pathology:
- - Necropsic examinations were performed on dead animals during the observation period or sacrificed at the end of the observation period. The abdominal and thoracic cavities were opened and a gross necropsy was performed.
- Animals that died during the observation period: For most animals and at all doses: A dilatation of the non-glandular part of the stomach, a necrotic aspect of the glandular part, as well as discolouration or necrosis of all the organs in contact with the stomach.
- In animals sacrificed at the end of the observation period: In most animals, induration of the glandular wall of the stomach was seen. - Interpretation of results:
- other: Not classified in accordance with EU criteria
- Conclusions:
- Under the conditions of this study, the oral LD50 value in Sprague-Dawley rats was estimated to be 5068 mg/kg.
- Executive summary:
The potential of the test material to cause acute toxicity via the oral route was determined in accordance with OECD guideline no. 401 and under GLP conditions using male and female Sprague-Dawley rats.
Five male and five female rats were exposed to an oral dose of test maerial at 3980, 5000, 5620 and 6300 mg/kg. Rats received a 10 mL/kg dose in the vehicle of water. A control group were dosed water only.
30 % mortality was observed at 3980 and 5000 mg/kg, 50 % mortality was seen at 5620 mg/kg and 90 % mortality was seen at 6300 mg/kg. There was no mortality observed in the vehicle control group. Observations during the study period included a depression with ataxia, piloerection, ptosis and at high dose levels, an inflated abdomen.
The following abnormalities were seen during the autopsy of animals that died during the study period: dilatation of the non-glandular part of the stomach, a necrotic aspect of the glandular part and discoloration or necrosis of all the organs in contact with the stomac. In the animals sacrificed at the end of the observation period induration of the glandular wall of the stomach was seen in most animals. The effects on the stomach are irritant/ corrosive effects due to the effects of H+ and not due to neodymium.
Under the conditions of this study, the oral LD50 value of the test material in Sprague-Dawley rats was estimated to be 5068 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 068 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: Directive 79/831 de la C.E.E –annexe V partie B
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 6 to 7 weeks
- Weight at study initiation: 160 to 200 g (males), 140 to 180 g (females)
- Housing: Animals kept individually in plastic cages (37.5 x 17.0 x 15.0 cm) containing sterilised sawdust
- Diet: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 1.5°C
- Humidity: 55 ± 15%
- Air changes: 10 per hr - Type of coverage:
- occlusive
- Vehicle:
- water
- Remarks:
- sterile
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal area
- Type of wrap if used: aluminium foil secured by a bandage
REMOVAL OF TEST SUBSTANCE
- Washing (if done): After 24 hours of application, the dressing was removed, the treated zone was then rinsed with lukewarm water.
TEST MATERIAL
- Amount(s) applied: 2000 mg/kg at 5 mL/kg
- Concentration: 40 g/100 mL - Duration of exposure:
- 24 hours
- Doses:
- 1
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Behaviour and mortality were observed immediately after the application of the test material and then 1 hour, 2 hours, 4 hours after and every day for 14 days. Body weight measurements was performed at 0, 7 and 14 days and at the death of the animal if it has survived more than 24 hours. Skin irritation was observed on day 1 and every day thereafter.
- Necropsy of survivors performed: yes autopsy was performed on animals found dead or sacrificed at the end of the observation period. - Preliminary study:
- A preliminary study was performed on 2 males and 2 females at 1000 and 2000 mg/kg. During the preliminary study no mortality was observed and as a result 2000 mg/kg was used for the main study.
- Key result
- Sex:
- male/female
- Dose descriptor:
- discriminating dose
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed during the 14 day period.
- Clinical signs:
- other: Daily observation of the animals for 14 days did not reveal any abnormalities attributable to treatment with the test material.
- Gross pathology:
- No macroscopically detectable abnormalities were observed at gross necropsy.
- Other findings:
- - Skin irritation at the test site:
Erythema was noted in all animals at day 1 - Interpretation of results:
- other: Not classified in accordance with EU criteria
- Conclusions:
- Under the conditions of this study no mortality was observed at 2000 mg/kg.
- Executive summary:
The potential toxicity of the test material via the dermal route was investigated under GLP conditions, using male and female rats in a 14 day long study.
Following a preliminary study which tested 1000 and 2000 mg/kg dose levels and saw no mortality the main study was conducted using 2000 mg/kg. Five male and five female rats were treated with the test material spread over the clipped dorsal area wrapped inaluminium foil secured by a band of plaster. The rats were exposed to the treatment for 24 hours before it was removed and washed with lukewarm water. Animals were observed for 14 days following treatment.
Under the conditions of this study none of the animals died prematurely, there were no clinical signs that could be attributed to treatment with the test material and all animals gained weight during the study. Erythema was noted at the test site in all animals at day 1.No macroscopically detectable abnormalities were observed at gross necropsy.
The LD50 was therefore determined to be in excess of 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Acute oral toxicity
The potential of the test material to cause acute toxicity via the oral route was determined following a method which was comparable to that which is outlined in the standardised guideline OECD 401. The study was conducted under GLP conditions using male and female Sprague-Dawley rats. The study was awarded a reliability score of 1 in accordance with the criteria set forth by Klimisch et al. (1997).
Five male and five female rats were exposed to an oral dose of test maerial at 3980, 5000, 5620 and 6300 mg/kg. Rats received a 10 mL/kg dose in the vehicle of water. A control group were dosed water only.
30 % mortality was observed at 3980 and 5000 mg/kg, 50 % mortality was seen at 5620 mg/kg and 90 % mortality was seen at 6300 mg/kg. There was no mortality observed in the vehicle control group. Observations during the study period included a depression with ataxia, piloerection, ptosis and at high dose levels, an inflated abdomen.
The following abnormalities were seen during the autopsy of animals that died during the study period: dilatation of the non-glandular part of the stomach, a necrotic aspect of the glandular part and discoloration or necrosis of all the organs in contact with the stomac. In the animals sacrificed at the end of the observation period induration of the glandular wall of the stomach was seen in most animals. The effects on the stomach are irritant/ corrosive effects due to the effects of H+ and not due to neodymium.
Under the conditions of this study, the oral LD50 value of the test material in Sprague-Dawley rats was estimated to be 5068 mg/kg.
Acute dermal toxicity
The potential toxicity of the test material via the dermal route was investigated under GLP conditions, using male and female rats in a 14 day long study. The study was awarded a reliability score of 2 in accordance with the criteria set forth by Klimisch et al. (1997).
Following a preliminary study which tested 1000 and 2000 mg/kg dose levels and saw no mortality the main study was conducte using 2000 mg/kg. Five male and five female rats were treated with the test material spread over the clipped dorsal area wrapped inaluminium foil secured by a band of plaster. The rats were exposed to the treatment for 24 hours before it was removed and washed with lukewarm water. Animals were observed for 14 days following treatment.
Under the conditions of this study none of the animals died prematurely, there were no clinical signs that could be attributed to treatment with the test material and all animals gained weight during the study. Erythema was noted at the test site in all animals at day 1. No macroscopically detectable abnormalities were observed at gross necropsy.
The LD50 was therefore determined to be in excess of 2000 mg/kg bw.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to acute toxicity via the oral and dermal routes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.